Pharmacological Characterization of an Antisense Knockdown Zebrafish Model of Dravet Syndrome: Inhib...
Pharmacological Characterization of an Antisense Knockdown Zebrafish Model of Dravet Syndrome: Inhibition of Epileptic Seizures by the Serotonin Agonist Fenfluramine: e0125898
About this item
Full title
Author / Creator
Journal title
Language
English
Formats
Subjects
More information
Scope and Contents
Contents
Dravet syndrome (DS) is one of the most pharmacoresistant and devastating forms of childhood epilepsy syndromes. Distinct de novo mutations in the SCN1A gene are responsible for over 80% of DS cases. While DS is largely resistant to treatment with existing anti-epileptic drugs, promising results have been obtained in clinical trials with human pati...
Alternative Titles
Full title
Pharmacological Characterization of an Antisense Knockdown Zebrafish Model of Dravet Syndrome: Inhibition of Epileptic Seizures by the Serotonin Agonist Fenfluramine: e0125898
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_1762362535
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1762362535
Other Identifiers
E-ISSN
1932-6203
DOI
10.1371/journal.pone.0125898
